Biotechnology at University of Hawaii at Manoa

Biotechnology programs nationally produce first-year earnings around $47,000, and University of Hawaii at Manoa's program likely falls in line with this pattern. With estimated debt of $20,400—slightly below the national median—graduates would face annual payments of roughly $230 per month on a standard 10-year plan, consuming about 6% of monthly gross income. This debt-to-earnings ratio of 0.43 suggests manageable repayment, though it's worth noting these figures come from comparable programs nationwide rather than UH Manoa's specific outcomes.

The challenge here is Hawaii's high cost of living. While $47,000 might stretch reasonably well in many mainland markets, Honolulu's housing costs alone could consume 40-50% of a biotechnician's salary. Similar programs in states like California or Massachusetts—also expensive markets with strong biotech industries—tend to show earnings in the $48,000-$53,000 range, suggesting graduates may face pressure to either advance quickly or relocate. The limited number of biotech employers in Hawaii compared to major mainland hubs could also constrain salary growth.

For students committed to staying in Hawaii, this estimated debt load at least doesn't compound an already difficult financial equation. But families should investigate whether UH Manoa's graduates typically remain in-state or migrate to West Coast biotech centers for better compensation—that mobility question matters more than the baseline numbers.